[HTML][HTML] B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experience
A D'Abramo, S Vita, A Beccacece, A Navarra… - Frontiers in …, 2024 - frontiersin.org
Objectives The aim of the study was to describe a cohort of B-cell-depleted
immunocompromised (IC) patients with prolonged or relapsing COVID-19 treated with …
immunocompromised (IC) patients with prolonged or relapsing COVID-19 treated with …
Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders
Background Vaccination constitutes a crucial preventive measure against COVID-19
infection. Concerns have been raised regarding the efficacy of vaccines in multiple sclerosis …
infection. Concerns have been raised regarding the efficacy of vaccines in multiple sclerosis …
[HTML][HTML] Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
SS Hamzavi, R Bahrololoom, S Saeb, NH Marandi… - BMC immunology, 2024 - Springer
Background For the past three years, the pandemic has had a major effect on global public
health, mainly on those with underlying medical conditions, such as people living with …
health, mainly on those with underlying medical conditions, such as people living with …
[HTML][HTML] The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine
M Balabandian, M Mohammadi… - Neurology …, 2024 - neurologyletters.com
Background: Microbial infections can induce immune responses and exacerbate the
symptoms of patients with autoinflammatory diseases such as multiple sclerosis (MS) …
symptoms of patients with autoinflammatory diseases such as multiple sclerosis (MS) …